Effective tuberculosis and hepatitis screening prior to anti-tnf-a therapy: Are we there yet?

Digestive Diseases and Sciences

Volumn 59, Issue 3, 2014, Pages 507-509

  Shahidi, Neal ^a   Bressler, Brian ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

COST EFFECTIVENESS ANALYSIS; CROHN DISEASE; DEVELOPING COUNTRY; FALSE POSITIVE RESULT; GEOGRAPHIC DISTRIBUTION; GOLD STANDARD; HEPATITIS; HIGH RISK POPULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INDUSTRIALIZATION; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; TUBERCULIN TEST;

ANTIBODIES, MONOCLONAL; CROHN DISEASE; HEPATITIS B; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LATENT TUBERCULOSIS;

EID: 84896695289     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2919-z     Document Type: Review

References (10)

1. Rahier JF, Ben-Horin S, Chowers Y, et al. European evidencebased consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2009;3:47-91.
2. Kucharz EJ, Korzeniewska-Kosela M, Kotulska A. Recommendations for prophylaxis and management of tuberculosis in patients treated with TNF-alpha antagonists. Reumatologia. 2008;46:51-54.
3. Van der Have M, Oldenburg B, Fidder HH, et al. Optimizing screening for tuberculosis and hepatitis B prior to starting tumor necrosis factor-alpha inhibitors in Crohn's disease. Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-013-2820-9.
4. Shahidi N, Fu YTN, Qian H, Bressler B. Performance of interferon-gamma release assays in patients with inflammatory bowel disease: A systematic review and meta-analysis. Inflamm Bowel Dis. 2012;18:2034-2042.
5. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update. Ann Intern Med. 2008;149:177-184.
6. Sadatsafavi M, Shahidi N, Marra F, et al. A statistical method was used for the meta-analysis of tests for latent TB in the absence of a gold standard, combining random-effect and latentclass methods to estimate test accuracy. J Clin Epidemiol. 2010;63:257-269.
7. Almadi MA, Ghosh S, Aljebreen AM. Differentiating intestinal tuberculosis from Crohn's disease: A diagnostic challenge. Am J Gastroenterol. 2009;104:1003-1012.
8. Molodecky NA, Shian Soon I, Rabi DM, Ghali WA, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46-54.
9. World Health Organization. Global tuberculosis report 2012. p. 13 Available from: Http://www.who.int/tb/publications/global-report/en/. Accessed July 2013.
10. Cattamanchi A, Smith S, Steingart KR, et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: A systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2011;56:230-238.